Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults

References

• American Psychiatric Association. Attention-deficit and disruptive behavior disorders. In: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, 4th Edn, Text Revision. Washington, DC: American Psychiatric Association, 2000:85-93
   Google Scholar
• Stefanatos GA, Baron IS. Attention-deficit/hyperactivity disorder: a neuropsychological perspective towards DSM-V. Neuropsychol Rev 2007;21:5-38
   Google Scholar
• Brown TE. DSM-IV: ADHD and executive function impairments. Adv Stud Med 2002;2:910-14
   Google Scholar
• Faraone SV, Biederman J, Spencer T, et al. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry 2006;163:1720-9
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Biederman J, Mick E. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol 2007;32:631-42
   PubMed Web of Science ®Google Scholar
• McGough JJ, Barkley RA. Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry 2004;161:1948-56
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Attention Deficit/Hyperactivity Disorder. 314.0x. Summary of changes under consideration for ADHD. Available at: http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid = 383 [Last accessed 17 March 2010]
   Google Scholar
• DuPaul GJ, Power TJ, Anastopoulos AD, et al. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press, 1998
   Google Scholar
• Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 2000;157:816-18
   PubMed Web of Science ®Google Scholar
• Steele M, Jensen PS, Quinn DMP. Remission versus response as the goal of therapy in ADHD: a new standard for the field? Clin Ther 2006;28:1892-908
   PubMed Web of Science ®Google Scholar
• Brown TE. Executive functions and attention deficit hyperactivity disorder: implications of two conflicting views. Int J Disability Develop Educ 2006;53:35-46
   Google Scholar
• Castellanos FX, Sonuga-Barke EJ, Milham MP, et al. Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn Sci 2006;10:117-23
   PubMed Web of Science ®Google Scholar
• Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997;121:65-94
   PubMed Web of Science ®Google Scholar
• Hervey AS, Epstein JN, Curry JF. Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review. Neuropsychology 2004;18:485-503
   PubMed Web of Science ®Google Scholar
• Barkley RA, Murphy KR. Impairment in occupational functioning and adult ADHD: the predictive utility of executive function (EF) ratings versus EF tests. Arch Clin Neuropsychol 2010;25:157-73
   PubMed Web of Science ®Google Scholar
• Shallice T, Burgess PW. Deficits in strategy application following frontal lobe damage in man. Brain 1991;114:727-41
   PubMed Web of Science ®Google Scholar
• Alderman N, Burgess PW, Knight C, et al. Ecological validity of a simplified version of the multiple errands shopping test. J Int Neuropsychol Soc 2003;9:31-44
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty CR, Fried R, et al. Stability of executive function deficits into young adult years: a prospective longitudinal follow-up study of grown up males with ADHD. Acta Psychiatr Scand 2007;116:129-36
   PubMed Web of Science ®Google Scholar
• Boonstra AM, Kooij JJ, Oosterlaan J, et al. To act or not to act, that's the problem: primarily inhibition difficulties in adult ADHD. Neuropsychology 2010;24:209-21
   PubMed Web of Science ®Google Scholar
• Brown TE. Brown Attention-Deficit Hyperactivity Disorder Scales for Adolescents and Adults. San Antonio, TX: The Psychological Corporation, 1996
   Google Scholar
• Vyvanse [package insert]. Wayne, PA, USA: Shire US Inc., 2010
   Google Scholar
• Wigal T, Brams M, Gasior M, et al. on behalf of the 316 Study Group. Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using the adult workplace environment design. Behav Brain Funct 2010;6:34
   PubMed Web of Science ®Google Scholar
• Lasko TA, Bhagwat JG, Zou KH, et al. The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 2005;38:404-15
   PubMed Web of Science ®Google Scholar
• Faries DE, Yalcin I, Harder D, et al. Validation of the ADHD Rating Scale as a clinician administered and scored instrument. J Atten Disord 2001;5:107-15
   Google Scholar
• Kaufman AS, Kaufman NL. KBIT-2: Kaufman Brief Intelligence Test, 2nd Upper Saddle River, NJ: Pearson Education, Inc., 2004
   Google Scholar
• Swanson J, Wigal S, Greenhill L, et al. Objective and subjective measures of the pharmacodynamic effects of Adderall® in the treatment of children with ADHD in a controlled laboratory classroom setting. Psychopharmacol Bull 1998;34:55-60
   PubMed Web of Science ®Google Scholar
• Brown T. Attention Deficit Disorder: The Unfocused Mind in Children and Adults. New Haven, CT: Yale University Press, 2005
   Google Scholar
• Swanson JM, Kraemer HC, Hinshaw SP, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 2001;40:168-79
   PubMed Web of Science ®Google Scholar
• Brown TE. Brown Attention-Deficit Disorder Scales for Children and Adolescents. San Antonio, TX: The Psychological Corp., 2001:1-149
   Google Scholar
• Adler LA, Goodman DW, Kollins SH, et al. on behalf of the 303 Study Group. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2008;69:1364-73
   PubMed Web of Science ®Google Scholar
• Weisler R, Young J, Mattingly G, et al. on behalf of the 304 Study Group. Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. CNS Spectr 2009;14:573-85
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Surman C, et al. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2006;59:829-35
   PubMed Web of Science ®Google Scholar
• Medori R, Ramos-Quiroga JA, Casas M, et al. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2008;63:981-9
   PubMed Web of Science ®Google Scholar
• Reimherr FW, Williams ED, Strong RE, et al. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry 2007;68:93-101
   PubMed Web of Science ®Google Scholar
• Weisler RH, Biederman J, Spencer TJ, et al. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr 2006;11:625-39
   PubMed Web of Science ®Google Scholar
• Biederman J, Spencer TJ, Wilens TE, et al. on behalf of the SLI 381.304 Study Group. Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr 2005;10:16-25
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Adler LA, McGough JJ, et al. the Adult ADHD Research Group. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2007;61:1380-7
   PubMed Web of Science ®Google Scholar
• Willcutt EG, Doyle AE, Nigg JT, et al. Validity of the executive function theory of attention-deficit/hyperactivity disorder: A meta-analytic review. Biol Psychiatry 2005;57:1336-46
   PubMed Web of Science ®Google Scholar
• Loo SK, Humphrey LA, Tapio T, et al. Executive functioning among Finnish adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46:1594-604
   PubMed Web of Science ®Google Scholar
• Nigg JT, Willcutt EG, Doyle AE, et al. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol Psychiatry 2005;57:1224-30
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty C, Fried R, et al. Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 2006;163:1730-8
   PubMed Web of Science ®Google Scholar
• Fallu A, Richard C, Prinzo R, et al. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder. Curr Med Res Opin 2006;22:2557-66
   PubMed Web of Science ®Google Scholar
• Biederman J, Seidman LJ, Petty CR, et al. Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2008;69:1150-6
   PubMed Web of Science ®Google Scholar
• Brown TE, Brams M, Gao J, et al. Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults. Postgrad Med 2010;122:7-17
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Adler LA, Weisler RH, et al. Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study. J Clin Psychiatry 2008;69:1437-48
   PubMed Web of Science ®Google Scholar
• Brown TE, Holdnack J, Saylor K, et al. Effect of atomoxetine on executive function impairments in adults with ADHD. J Atten Disord 2011;15:130-8
   PubMed Web of Science ®Google Scholar
• Findling RL, Adeyi B, Chen G, et al. Clinical response and symptomatic remission in children treated with lisdexamfetamine dimesylate for attention-deficit/hyperactivity disorder. CNS Spectrums 2010;15:559-68
   Web of Science ®Google Scholar